We use cookies to offer you the best experience on our site. You can find out more about the cookies we use or disable them in the settings. Cookie settings
News
High importance
ExoXpert, a CDMO launched by EXO Biologics to service increasing worldwide demand for exosomes
Research Paper : EVs From MS Umbilical Cord Cells Exert Protection Against Oxidative Stress and Fibrosis in a Rat Model of BPD
High importance
EXO Biologics Pioneers with EVENEW Clinical Trial in Broncho Pulmonary Dysplasia.
EXO Biologics Granted Orphan Drug Designation by FDA for EXOB-001 for Prevention of BPD in Preterm newborns.
EXO Biologics Received FDA Rare Pediatric Disease Designation for EXOB-001 for Prevention of BPD in Preterm newborns.
EXO Biologics Secures a Total of €8.7 Million in Financing
About us
EXO Biologics mission is to provide affordable and accessible exosomes therapy to patients with unmet medical needs.